Amundi’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,401
| Closed | -$11.5K | – | 2074 |
|
|
2025
Q1 | $11.5K | Buy |
2,401
+128
| +6% | +$616 | ﹤0.01% | 1877 |
|
|
2024
Q4 | $16.5K | Sell |
2,273
-68,502
| -97% | -$497K | ﹤0.01% | 1896 |
|
|
2024
Q3 | $456K | Sell |
70,775
-6,911
| -9% | -$44.5K | ﹤0.01% | 1449 |
|
|
2024
Q2 | $571K | Buy |
77,686
+6,064
| +8% | +$44.6K | ﹤0.01% | 1323 |
|
|
2024
Q1 | $530K | Buy |
71,622
+15,065
| +27% | +$111K | ﹤0.01% | 1412 |
|
|
2023
Q4 | $758K | Sell |
56,557
-32,005
| -36% | -$429K | ﹤0.01% | 1369 |
|
|
2023
Q3 | $565K | Buy |
88,562
+32,662
| +58% | +$208K | ﹤0.01% | 1392 |
|
|
2023
Q2 | $413K | Buy |
55,900
+51,660
| +1,218% | +$381K | ﹤0.01% | 1423 |
|
|
2023
Q1 | $27.3K | Sell |
4,240
-2,949
| -41% | -$19K | ﹤0.01% | 1941 |
|
|
2022
Q4 | $56.9K | Buy |
7,189
+2,949
| +70% | +$23.4K | ﹤0.01% | 1676 |
|
|
2022
Q3 | $49K | Buy |
+4,240
| New | +$49K | ﹤0.01% | 1669 |
|